Who Paid My Doc
NexGen TM Tibia Clinical Outcomes Study
Research payments
$229,723
Through program year 2024, $229,723 in research payments was reported against NexGen TM Tibia Clinical Outcomes Study, across 116 payments, paid by Zimmer Biomet Holdings, Inc..
- Paid by
- Zimmer Biomet Holdings, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $8,547 | 3 |
| 2023 | Research | $21,031 | 12 |
| 2022 | Research | $22,862 | 6 |
| 2021 | Research | $39,605 | 25 |
| 2020 | Research | $43,097 | 22 |
| 2019 | Research | $94,581 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Louis Kwong Glendale, CA Named on 21 payments
- Ian Weber Louisville, CO Named on 15 payments
- Lindsey Rolston New Castle, IN Named on 14 payments
- Richard Rames Chesterfield, MO Named on 14 payments
- Craig Israelite Philadelphia, PA Named on 13 payments
- Timothy Williams Westfield, IN Named on 12 payments
- John Moore Pinehurst, NC Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.